EA201891803A1 - Фармацевтические составы в форме гранул, содержащие диметилфумарат - Google Patents
Фармацевтические составы в форме гранул, содержащие диметилфумаратInfo
- Publication number
- EA201891803A1 EA201891803A1 EA201891803A EA201891803A EA201891803A1 EA 201891803 A1 EA201891803 A1 EA 201891803A1 EA 201891803 A EA201891803 A EA 201891803A EA 201891803 A EA201891803 A EA 201891803A EA 201891803 A1 EA201891803 A1 EA 201891803A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- granules
- pharmaceutical compositions
- pharmaceutical composition
- granules containing
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
В данном изобретении предложены новые фармацевтические композиции на основе диметилфумарата. Фармацевтические композиции по данному изобретению содержат первую фармацевтическую композицию в форме гранул и вторую фармацевтическую композицию в форме гранул, причем первая фармацевтическая композиция в форме гранул представляет собой покрытую энтеросолюбильной оболочкой композицию с быстрым высвобождением, а вторая фармацевтическая композиция в форме гранул представляет собой покрытую энтеросолюбильной оболочкой композицию с контролируемым высвобождением, при этом как первая фармацевтическая композиция в форме гранул, так и вторая фармацевтическая композиция в форме гранул содержат диметилфумарат. Также включены способы применения фармацевтических композиций по данному изобретению для лечения рассеянного склероза.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662294054P | 2016-02-11 | 2016-02-11 | |
PCT/US2017/016934 WO2017139331A1 (en) | 2016-02-11 | 2017-02-08 | Pharmaceutical bead formulations comprising dimethyl fumarate |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201891803A1 true EA201891803A1 (ru) | 2019-01-31 |
Family
ID=58057304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201891803A EA201891803A1 (ru) | 2016-02-11 | 2017-02-08 | Фармацевтические составы в форме гранул, содержащие диметилфумарат |
Country Status (12)
Country | Link |
---|---|
US (2) | US11033509B2 (ru) |
EP (1) | EP3413879A1 (ru) |
JP (2) | JP6902043B2 (ru) |
KR (1) | KR20180108814A (ru) |
CN (1) | CN108778256A (ru) |
AU (1) | AU2017217464B2 (ru) |
CA (1) | CA3013472A1 (ru) |
EA (1) | EA201891803A1 (ru) |
IL (1) | IL261073A (ru) |
MA (1) | MA44010A (ru) |
MX (1) | MX2018009749A (ru) |
WO (1) | WO2017139331A1 (ru) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA201891803A1 (ru) * | 2016-02-11 | 2019-01-31 | Байоджен Ма Инк. | Фармацевтические составы в форме гранул, содержащие диметилфумарат |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2965751A1 (en) * | 2004-10-08 | 2016-01-13 | Forward Pharma A/S | Controlled release pharmaceutical compositions comprising a fumaric acid ester |
US20080187579A1 (en) * | 2007-02-01 | 2008-08-07 | Pavan Bhat | Extended-release dosage form |
US20130216615A1 (en) * | 2012-02-07 | 2013-08-22 | David Goldman | Pharmaceutical Compositions Containing Dimethyl Fumarate |
WO2015042294A1 (en) * | 2013-09-18 | 2015-03-26 | Xenoport, Inc. | Nanoparticle compositions of dimethyl fumarate |
US10172794B2 (en) * | 2013-12-13 | 2019-01-08 | Biogen Ma Inc. | Controlled release dosage form for once daily administration of dimethyl fumarate |
MA40982A (fr) * | 2014-11-19 | 2017-09-26 | Biogen Ma Inc | Formulation de bille pharmaceutique comprenant du fumarate de diméthyle |
EP3310341A1 (en) * | 2015-06-17 | 2018-04-25 | Biogen MA Inc. | Dimethyl fumarate particles and pharmaceutical compositions thereof |
CN104971048B (zh) * | 2015-07-01 | 2019-01-18 | 上海汇伦医药科技有限公司 | 富马酸二甲酯肠溶微丸及其制备方法 |
EA201891803A1 (ru) * | 2016-02-11 | 2019-01-31 | Байоджен Ма Инк. | Фармацевтические составы в форме гранул, содержащие диметилфумарат |
-
2017
- 2017-02-08 EA EA201891803A patent/EA201891803A1/ru unknown
- 2017-02-08 US US16/076,849 patent/US11033509B2/en active Active
- 2017-02-08 MA MA044010A patent/MA44010A/fr unknown
- 2017-02-08 CA CA3013472A patent/CA3013472A1/en active Pending
- 2017-02-08 WO PCT/US2017/016934 patent/WO2017139331A1/en active Application Filing
- 2017-02-08 CN CN201780016727.0A patent/CN108778256A/zh active Pending
- 2017-02-08 MX MX2018009749A patent/MX2018009749A/es unknown
- 2017-02-08 AU AU2017217464A patent/AU2017217464B2/en not_active Expired - Fee Related
- 2017-02-08 JP JP2018542269A patent/JP6902043B2/ja active Active
- 2017-02-08 KR KR1020187025947A patent/KR20180108814A/ko not_active Application Discontinuation
- 2017-02-08 EP EP17706072.0A patent/EP3413879A1/en not_active Withdrawn
-
2018
- 2018-08-09 IL IL261073A patent/IL261073A/en unknown
-
2021
- 2021-05-13 US US17/319,694 patent/US20210369629A1/en not_active Abandoned
- 2021-06-18 JP JP2021101599A patent/JP2021152050A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
MA44010A (fr) | 2018-12-19 |
JP6902043B2 (ja) | 2021-07-14 |
JP2021152050A (ja) | 2021-09-30 |
US11033509B2 (en) | 2021-06-15 |
US20190046456A1 (en) | 2019-02-14 |
CA3013472A1 (en) | 2017-08-17 |
AU2017217464B2 (en) | 2022-11-10 |
KR20180108814A (ko) | 2018-10-04 |
IL261073A (en) | 2018-10-31 |
EP3413879A1 (en) | 2018-12-19 |
WO2017139331A8 (en) | 2017-10-12 |
MX2018009749A (es) | 2019-02-07 |
JP2019504859A (ja) | 2019-02-21 |
WO2017139331A1 (en) | 2017-08-17 |
US20210369629A1 (en) | 2021-12-02 |
AU2017217464A1 (en) | 2018-08-30 |
CN108778256A (zh) | 2018-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201991862A1 (ru) | Композиции и способы, предназначенные для лечения гемоглобинопатий | |
EA201891083A1 (ru) | Составы антител к cd38 для подкожного введения и их применение | |
EA201890395A1 (ru) | Пролекарства аналогов глутамина | |
EA201891532A1 (ru) | Композиции и способы лечения гемоглобинопатий | |
MA46389A (fr) | Variants de l'endonucléase homing pd1, compositions et procédés d'utilisation | |
EA201890749A1 (ru) | ИНГИБИТОРЫ АЦЕТИЛ-КоА-КАРБОКСИЛАЗЫ (ACC) И ИХ ПРИМЕНЕНИЕ | |
EA201890949A1 (ru) | СЛОЖНОЭФИРНЫЕ ИНГИБИТОРЫ АЦЕТИЛ-КоА-КАРБОКСИЛАЗЫ И ВАРИАНТЫ ИХ ПРИМЕНЕНИЯ | |
BR112019012343A2 (pt) | anticorpos il-11ra | |
EA201991431A1 (ru) | УСИЛЕННЫЙ ОПОСРЕДОВАННЫЙ ТРАНСПОЗОНАМИ СЕМЕЙСТВА hAT ПЕРЕНОС ГЕНОВ И АССОЦИИРОВАННЫЕ КОМПОЗИЦИИ, СИСТЕМЫ И СПОСОБЫ | |
EA201890068A1 (ru) | Частицы диметилфумарата и фармацевтические композиции на их основе | |
EA201991720A1 (ru) | Антитела к альфа-синуклеину и их применения | |
MX2022000053A (es) | Moduladores de interaccion de sestrina-gator2 y sus usos. | |
EA201791113A1 (ru) | Фармацевтические составы в виде гранул, содержащие диметилфумарат | |
EA201890810A1 (ru) | Соединения, эффективные для лечения гепатотоксичности и стеатоза печени, и их применение | |
EA202092692A1 (ru) | Аналоги рапамицина и их применения | |
MX2019005322A (es) | Composiciones de recubrimiento y metodos de uso de las mismas. | |
MA48942A (fr) | Composés thérapeutiques, compositions et procédés d'utilisation associés | |
EA201790565A1 (ru) | Композиции и способы для лечения предраковых поражений кожи | |
PH12018502233A1 (en) | ErbB INHIBITORS AND USES THEREOF | |
EA201792262A1 (ru) | Пироглутамат вортиоксетина | |
DK3733712T3 (da) | Programmer og fremgangsmåder til behandling af multipel sklerose under anvendelse af ofatumumab | |
EA201990064A1 (ru) | Противомалярийные композиции и варианты их применения | |
BR112017000211A2 (pt) | composição de revestimento estável | |
MA43848A (fr) | Composés deutérés pour le traitement d'hémopathies malignes, compositions et procédés associés | |
EA201891803A1 (ru) | Фармацевтические составы в форме гранул, содержащие диметилфумарат |